Required minimum distributions (RMDs) are the minimum amounts you must withdraw from your retirement accounts each year. You generally must start taking withdrawals from your traditional IRA, …

Jul 15, 2020 · Minimal residual disease (MRD) is common in patients with blood cancers, such as leukemia, lymphoma and multiple myeloma. But what does this mean for patients and their need for …

Minimal residual disease (MRD), also known as molecular residual disease, or measurable residual disease, is the medical condition in which small number of cancer cells persist in a patient either …

Dec 15, 2025 · Measurable residual disease (MRD) monitoring has become a critical component in the management of acute myeloid leukemia (AML), to inform prognosis, guide therapy, and serve as a …

Signatera™ is a sensitive ctDNA test for colorectal cancer that can identify relapse sooner than standard tools. Click here to learn more about it.

Mar 17, 2022 · Learn all about minimal residual disease (MRD), how doctors test for it, what your results may mean, and what you can do next.

Minimal residual disease testing is used mostly for blood cancers such as lymphoma and leukemia. Also called measurable residual disease and MRD. A term used to describe a very small number of …

3 days ago · An overview of the FDA’s draft guidance on MRD as a clinical trial endpoint, with expert insight on what it means for drug development in multiple myeloma.

Jul 1, 2025 · Learn how physicians use this crucial tool in modern oncology to improve patient outcomes. Minimal residual disease (MRD) testing is a critical tool for assessing the long-term …

To measure MRD, your bone marrow biopsy sample is tested using methods that are sensitive enough to find as few as 1 malignant plasma cell out of 1 million normal plasma cells.